Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

AGC Biologics Expands Operations in Bothell, Washington

03/30/2018
AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, is expanding its campus with the addition of a new building complex to house the company's global headquarters, 20 miles northeast of Seattle, in Bothell, Washington.

The new complex is located adjacent to the existing AGC Biologics facility in Bothell, and spans more than 150,000 square feet. The new addition will hold the company's process development labs and corporate administrative offices, and will provide expansion space for additional manufacturing capacity.

According to company officials, the new facilities allow AGC Biologics to continue its expansion in the United States, and will include a new R&D center dedicated to novel manufacturing technologies for faster development of therapeutic proteins.

"The expansion of our Bothell site is another substantial milestone for AGC Biologics and a commitment to our operations in Washington State. We continue to demonstrate our dedication to sustained growth in order to support our customers' increasing demand for both mammalian and microbial development and manufacturing services," said Gustavo Mahler, President & CEO of AGC Biologics.

"These new state-of-the-art facilities will enable us to meaningfully advance and further integrate the development, manufacturing, and commercial functions within our dynamic global headquarters, as well as provide additional footprint for further manufacturing expansion,” he added.

Article Discussion

Share